Cargando…

Using biomarkers to predict progression from clinically isolated syndrome to multiple sclerosis

BACKGROUND: Detection of brain lesions disseminated in space and time by magnetic resonance imaging remains a cornerstone for the diagnosis of clinically definite multiple sclerosis. We have sought to determine if gene expression biomarkers could contribute to the clinical diagnosis of multiple scle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tossberg, John T, Crooke, Philip S, Henderson, Melodie A, Sriram, Subramaniam, Mrelashvili, Davit, Vosslamber, Saskia, Verweij, Cor L, Olsen, Nancy J, Aune, Thomas M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850501/ https://www.ncbi.nlm.nih.gov/pubmed/24088512 http://dx.doi.org/10.1186/2043-9113-3-18

Ejemplares similares

Gene expression signatures: biomarkers toward diagnosing multiple sclerosis
por: Tossberg, John T., et al.
Publicado: (2011)

Defective structural RNA processing in relapsing-remitting multiple sclerosis
por: Spurlock, Charles F, et al.
Publicado: (2015)

Using gene expression data to identify certain gastro-intestinal diseases
por: Crooke, Philip S, et al.
Publicado: (2012)

Expression of IL-33 and its epigenetic regulation in multiple sclerosis
por: Zhang, Fanglin, et al.
Publicado: (2014)

Reduced A-to-I editing of endogenous Alu RNAs in lung after SARS-CoV-2 infection
por: Crooke, Philip S., et al.
Publicado: (2021)

Alu RNA Structural Features Modulate Immune Cell Activation and A-to-I Editing of Alu RNAs Is Diminished in Human Inflammatory Bowel Disease
por: Aune, Thomas M., et al.
Publicado: (2022)

Reduced RNA adenosine-to-inosine editing in hippocampus vasculature associated with Alzheimer’s disease
por: Crooke, Philip S, et al.
Publicado: (2022)

Longitudinal changes in the expression of IL-33 and IL-33 regulated genes in relapsing remitting MS
por: Sriram, Subramaniam, et al.
Publicado: (2018)

Expression and functions of long noncoding RNAs during human T helper cell differentiation
por: Spurlock, Charles F., et al.
Publicado: (2015)

Nanoparticle Delivery of Immunostimulatory Alu RNA for Cancer Immunotherapy
por: Garland, Kyle M., et al.
Publicado: (2023)

Combining DNA-microarray data in systemic lupus erythematosus
por: Verweij, Cornelis L, et al.
Publicado: (2011)

Moving towards personalized medicine in rheumatoid arthritis
por: de Jong, Tamarah D, et al.
Publicado: (2014)

A simplified method to produce mRNAs and functional proteins from synthetic double-stranded DNA templates
por: Tossberg, John T, et al.
Publicado: (2020)

The role of infections in the pathogenesis and course of multiple sclerosis
por: Pawate, Siddharama, et al.
Publicado: (2010)

Lineage-specific adjacent IFNG and IL26 genes share a common distal enhancer element
por: Collins, Patrick L., et al.
Publicado: (2012)

Perception of stigma in patients with primary progressive multiple sclerosis
por: Pérez-Miralles, Francisco, et al.
Publicado: (2019)

Pharmacogenomics of Interferon-ß Therapy in Multiple Sclerosis: Baseline IFN Signature Determines Pharmacological Differences between Patients
por: van Baarsen, Lisa G. M., et al.
Publicado: (2008)

Longitudinal change in TSPO PET imaging in progressive multiple sclerosis
por: Kang, Yeona, et al.
Publicado: (2021)

Type I interferon response gene expression in established rheumatoid arthritis is not associated with clinical parameters
por: de Jong, Tamarah D., et al.
Publicado: (2016)

Elevated fecal levels of the inflammatory biomarker calprotectin in early systemic sclerosis
por: Hamberg, Viggo, et al.
Publicado: (2022)

Cerebrospinal fluid extracellular vesicle enrichment for protein biomarker discovery in neurological disease; multiple sclerosis
por: Welton, Joanne L., et al.
Publicado: (2017)

A single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis
por: Wootla, Bharath, et al.
Publicado: (2015)

Epigenetic Activation and Silencing of the Gene that Encodes IFN-γ
por: Aune, Thomas M., et al.
Publicado: (2013)

Role of HDAC3 on p53 Expression and Apoptosis in T Cells of Patients with Multiple Sclerosis
por: Zhang, Fanglin, et al.
Publicado: (2011)

DNA methylation changes in CD4(+) T cells isolated from multiple sclerosis patients on dimethyl fumarate
por: Maltby, Vicki E, et al.
Publicado: (2018)

Interleukin 1β—A Potential Salivary Biomarker for Cancer Progression?
por: Idris, Adi, et al.
Publicado: (2015)

Reference videos reduce variability of motor dysfunction assessments in multiple sclerosis
por: D’Souza, Marcus, et al.
Publicado: (2018)

Serum levels of inflammasome pathway factors in clinically isolated syndrome and multiple sclerosis patients: a pilot study
por: TAMAM, YUSUF, et al.
Publicado: (2020)

Is cumulative frequency of mitochondrial DNA variants a biomarker for colorectal tumor progression?
por: Aikhionbare, Felix O, et al.
Publicado: (2004)

Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis
por: Turner, Martin R, et al.
Publicado: (2015)

Analysis of ultrastructural glomerular basement membrane lesions and podocytes associated with proteinuria and sclerosis in Osborne-Mendel rats with progressive glomerulonephropathy
por: Yasuno, Kyohei, et al.
Publicado: (2013)

Effects of Repeated Intrathecal Triamcinolone-Acetonide Application on Cerebrospinal Fluid Biomarkers of Axonal Damage and Glial Activity in Multiple Sclerosis Patients
por: Rommer, P. S., et al.
Publicado: (2014)

MicroRNAs in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progression
por: Martinez, Bridget, et al.
Publicado: (2019)

CryoEM at IUCrJ: a new era
por: Subramaniam, Sriram, et al.
Publicado: (2016)

Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets
por: De Stefano, Nicola, et al.
Publicado: (2017)

Enlarged perivascular spaces are not associated with vascular co-morbidities, clinical outcomes, and brain volumes in people with secondary progressive multiple sclerosis
por: Wooliscroft, Lindsey, et al.
Publicado: (2020)

Effect of prednisone on type I interferon signature in rheumatoid arthritis: consequences for response prediction to rituximab
por: de Jong, Tamarah D, et al.
Publicado: (2015)

Automated extraction of clinical traits of multiple sclerosis in electronic medical records
por: Davis, Mary F, et al.
Publicado: (2013)

Serum neurofilament light as a biomarker in progressive multiple sclerosis
por: Kapoor, Raju, et al.
Publicado: (2020)

MicroRNAs as disease progression biomarkers and therapeutic targets in experimental autoimmune encephalomyelitis model of multiple sclerosis
por: Martinez, Bridget, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_aolshslarrn2hn0bmjf7ehho47